Immune Checkpoint Inhibitors and Anti-vascular Endothelial Growth Factor Antibody/Tyrosine Kinase Inhibitors With or Without TACE for Advanced HCC With Vascular Invasions
Clinical trial NCT06881446 · COMPLETED
Trial details
- NCT number
- NCT06881446
- Sponsor
- Zhongda Hospital
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-06-01
- Primary completion
- 2025-03-30
- Enrollment
- 2651
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.